171 related articles for article (PubMed ID: 24980806)
101. Characterization of polarized expression of point- or deletion-mutated human BCRP/ABCG2 in LLC-PK1 cells.
Takada T; Suzuki H; Sugiyama Y
Pharm Res; 2005 Mar; 22(3):458-64. PubMed ID: 15835752
[TBL] [Abstract][Full Text] [Related]
102. Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies.
Yuan ZW; Li YZ; Liu ZQ; Feng SL; Zhou H; Liu CX; Liu L; Xie Y
Pharmacol Res; 2018 Feb; 128():153-166. PubMed ID: 28958806
[TBL] [Abstract][Full Text] [Related]
103. Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions.
Zolnerciks JK; Booth-Genthe CL; Gupta A; Harris J; Unadkat JD
J Pharm Sci; 2011 Aug; 100(8):3055-3061. PubMed ID: 21484807
[TBL] [Abstract][Full Text] [Related]
104. BacMam recombinant baculovirus in transporter expression: a study of BCRP and OATP1B1.
Hassan NJ; Pountney DJ; Ellis C; Mossakowska DE
Protein Expr Purif; 2006 Jun; 47(2):591-8. PubMed ID: 16481201
[TBL] [Abstract][Full Text] [Related]
105. Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis.
Lala P; Ito S; Lingwood CA
J Biol Chem; 2000 Mar; 275(9):6246-51. PubMed ID: 10692420
[TBL] [Abstract][Full Text] [Related]
106. Ketamine Pharmacokinetics and Pharmacodynamics Are Altered by P-Glycoprotein and Breast Cancer Resistance Protein Efflux Transporters in Mice.
Ganguly S; Panetta JC; Roberts JK; Schuetz EG
Drug Metab Dispos; 2018 Jul; 46(7):1014-1022. PubMed ID: 29674491
[TBL] [Abstract][Full Text] [Related]
107. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
[TBL] [Abstract][Full Text] [Related]
108. Effect of ion-pair formation with bile salts on the in vitro cellular transport of berberine.
Chae HW; Kim IW; Jin HE; Kim DD; Chung SJ; Shim CK
Arch Pharm Res; 2008 Jan; 31(1):103-10. PubMed ID: 18277615
[TBL] [Abstract][Full Text] [Related]
109. Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan.
Su Y; Hu P; Lee SH; Sinko PJ
J Pharm Pharm Sci; 2007; 10(4):519-36. PubMed ID: 18261372
[TBL] [Abstract][Full Text] [Related]
110. Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy.
Kim M; Laramy JK; Gampa G; Parrish KE; Brundage R; Sarkaria JN; Elmquist WF
Drug Metab Dispos; 2019 Dec; 47(12):1403-1414. PubMed ID: 31619389
[TBL] [Abstract][Full Text] [Related]
111. Screening of pharmacokinetic properties of fifty dihydropyrimidin(thi)one derivatives using a combo of in vitro and in silico assays.
Matias M; Fortuna A; Bicker J; Silvestre S; Falcão A; Alves G
Eur J Pharm Sci; 2017 Nov; 109():334-346. PubMed ID: 28842351
[TBL] [Abstract][Full Text] [Related]
112. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil.
Higashi H; Watanabe N; Tamura R; Taguchi M
Biol Pharm Bull; 2017; 40(8):1314-1319. PubMed ID: 28769012
[TBL] [Abstract][Full Text] [Related]
113. A modified coumarinic acid-based cyclic prodrug of an opioid peptide: its enzymatic and chemical stability and cell permeation characteristics.
Ouyang H; Tang F; Siahaan TJ; Borchardt RT
Pharm Res; 2002 Jun; 19(6):794-801. PubMed ID: 12134949
[TBL] [Abstract][Full Text] [Related]
114. Elucidation of Transport Mechanism of Paeoniflorin and the Influence of Ligustilide, Senkyunolide I and Senkyunolide A on Paeoniflorin Transport through Mdck-Mdr1 Cells as Blood-Brain Barrier in Vitro Model.
Hu PY; Liu D; Zheng Q; Wu Q; Tang Y; Yang M
Molecules; 2016 Mar; 21(3):300. PubMed ID: 26950101
[TBL] [Abstract][Full Text] [Related]
115. Mechanism for ginkgolic acid (15 : 1)-induced MDCK cell necrosis: Mitochondria and lysosomes damages and cell cycle arrest.
Yao QQ; Liu ZH; Xu MC; Hu HH; Zhou H; Jiang HD; Yu LS; Zeng S
Chin J Nat Med; 2017 May; 15(5):375-383. PubMed ID: 28558873
[TBL] [Abstract][Full Text] [Related]
116. Transfected rat cMOAT is functionally expressed on the apical membrane in Madin-Darby canine kidney (MDCK) cells.
Kinoshita S; Suzuki H; Ito K; Kume K; Shimizu T; Sugiyama Y
Pharm Res; 1998 Dec; 15(12):1851-6. PubMed ID: 9892468
[TBL] [Abstract][Full Text] [Related]
117. A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.
Karlgren M; Simoff I; Backlund M; Wegler C; Keiser M; Handin N; Müller J; Lundquist P; Jareborg AC; Oswald S; Artursson P
J Pharm Sci; 2017 Sep; 106(9):2909-2913. PubMed ID: 28450237
[TBL] [Abstract][Full Text] [Related]
118. Inhibition of P-Glycoprotein Mediated Efflux in Caco-2 Cells by Phytic Acid.
Li L; Fu Q; Xia M; Xin L; Shen H; Li G; Ji G; Meng Q; Xie Y
J Agric Food Chem; 2018 Jan; 66(4):988-998. PubMed ID: 29282978
[TBL] [Abstract][Full Text] [Related]
119. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.
Tanaka K; Hirai M; Tanigawara Y; Ueda K; Takano M; Hori R; Inui K
Biochem Pharmacol; 1997 Mar; 53(5):741-6. PubMed ID: 9113094
[TBL] [Abstract][Full Text] [Related]
120. Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting.
Patel NC; Feng B; Hou X; West MA; Trapa PE; Sciabola S; Verhoest P; Liras JL; Maurer TS; Wager TT
ACS Chem Neurosci; 2021 Mar; 12(6):1007-1017. PubMed ID: 33651587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
